Home › Research › Topics › advancing
advancing
3 studies tagged advancing, dated 2009-02-23 to 2025-07-15. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Incretin-Based Therapies in Alzheimer's and Parkinson's Disease: Advancing Neuroprotection With Dual and Triple Agonists-A Review 2025-07-15
- The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health 2025-04-17
- Arterial pulse wave velocity and cognition with advancing age 2009-02-23
Studies
3 studies carry this tag.
Date range
2009 to 2025
Top journals
- Current issues in molecular biology 1
- Health science reports 1
- Hypertension (Dallas, Tex. : 1979) 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Emerging evidence highlights disrupted insulin signaling in AD and, to a lesser extent, in PD, suggesting that insulin plays a key neuroprotective role.
-
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have emerged as a promising therapeutic option beyond their established role in managing type 2 diabetes mellitus (T2DM) and obesity.
-
We hypothesized that carotid-femoral pulse wave velocity (PWV), a marker of arterial stiffness, interacts with age such that the magnitude of associations between PWV and cognitive performance are greater with increasing age and that this interaction is observed despite adjustments for demographic variables, mean arterial pressure, and cardiovascular risk factors.